ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,537, issued on May 6, was assigned to LaNova Medicines Ltd. (Shanghai).
"Compounds, compositions and methods" was invented by Runsheng Li (Shanghai), Wentao Huang (Shanghai), Zhifang Liu (Shanghai) and Ying Qin Zang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to anticancer compounds, including, but not limited to, antibody-drug conjugates using the same, which compounds and ACDs thereof are suitable for the treatment of cancer."
The patent was filed on Feb. 6, 2024, under Application No. 18/433,717.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacg...